23andMe's test results for cancer risk can be costly to confirm

23andMe's test results for cancer risk can be costly to confirm

23andMe's test for a breast-cancer gene can reveal life-changing information, but can also lead down an expensive and complicated path

Angelica LaVito | @angelicalavito

Published 12:22 PM ET Sun, 24 June 2018 Updated 4:06 PM ET Sun, 24 June 2018CNBC.com

• 23andMe received approval from the Food and Drug Administration earlier this year to test for three BRCA mutations with its at-home ancestry tests earlier this year.
• 23andMe screens for only three BRCA mutations that are most common among people of Ashkenazi Jewish descent.
• Color Genomics is offering confirmation testing to people who have received a positive result using 23andMe.